Bioscience
Building Arizona as a global center for research and commercialization in the biosciences.
Connect with Flinn Bioscience: Stay up to date. Join our email list.
Bioscience in Arizona
The Flinn Foundation supports the biosciences in Arizona through research and entrepreneurship grants as well as stewardship of Arizona’s Bioscience Roadmap, guiding the growth and development of the state’s bioscience sector through 2025.
The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.
The biosciences improve our world by developing treatments for health afflictions with safer and more affordable medicines, creating diagnostics that gauge and prevent illness, and strengthening our food supply. In addition, the biosciences strengthen and diversify our economy by creating cutting-edge companies and high-paying jobs.
Flinn launches RFP for seed grants program. Apply by Sept. 26
The Flinn Foundation Seed Grants to Promote Translational Research Program opened its application Aug. 1 for a new round of research grants. The deadline to apply is Sept. 26.
The program funds about 10 research teams each year affiliated with an Arizona university, research institution, or health-care system that are advancing new products or services addressing significant clinical needs. Program awardees each receive a $100,000 grant over 18 months, plus programmatic benefits. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year. [Apply]
Sampath Rangasamy’s personal journey leading to improved diabetes treatment
Sampath Rangasamy was just a child when he was taken by his father past the rice fields and palm trees of his rural South India farming village to a nearby medical clinic. He had been losing weight, was seriously ill and needed immediate care. Once he was stabilized, he learned that his daily life would never be the same.
Rangasamy was told by his doctor there would not be a quick cure for his Type 1 diabetes. Today, the Flinn seed grant awardee not only successfully manages his condition, but is developing a smartphone application to support others in the same situation. [Read more]
Joanna Yang Yowler named new Flinn bioscience program manager
Joanna Yang Yowler, Ph.D., joined the Flinn Foundation in August as program manager, translational biosciences and entrepreneurship. Yang Yowler will support the translational research seed grants and bioscience entrepreneurship programs and be present in the community to help foster Arizona’s bioscience ecosystem.
Before joining Flinn, Yang Yowler developed community-based research partnerships in health and education at Mayo Clinic in partnership with InSciEd Out Foundation. After leaving Mayo, she directed the Tenderloin Science Project for R&D Impact Foundation in San Francisco. Joanna earned her doctorate in biomedical sciences from Mayo Clinic’s Clinical and Translational Sciences program. As a Flinn Scholar, she graduated with a bachelor’s in biological sciences from Barrett, the Honors College at Arizona State University. [Read bio]
Three bioscience growth areas identified in Flinn Foundation-sponsored study
A new study of the Phoenix area’s bioscience ecosystem has identified three areas poised for rapid growth and global impact at the Phoenix Bioscience Core and in surrounding regional hubs of research and innovation.
The report, “Leveraging the Phoenix Region’s Bioscience Assets for Sustained Economic Growth,” identifies how precision oncology/medicine; digital health, weartech, and medtech; and translational neurosciences can grow the state’s bioscience and biomedical industry through partnerships between industry, clinical care, and academic research and development. [Read more]
New Arizona bioscience data shows sustained growth, new records
The growth in Arizona’s bioscience ecosystem continues with new record highs in bioscience jobs and wages, National Institutes of Health funding, university research and development, and certain measures of university technology-transfer—plus an increase in venture capital funding.
The Flinn Foundation hosted its annual Bioscience Progress Report event in April. TEConomy Partners presented the latest performance metrics while a panel discussed the rapid growth of medtech in Arizona. The Progress Report brochure, the most recent data on key metrics, a recording of the event, and more information about Arizona’s Bioscience Roadmap are all now available. [Learn more]
News and Updates
Bioscience
Arizona Bioscience News: Brooks Rehabilitation hospital; New Banner Health president; ASU InvestU event
$70 million physical rehabilitation hospital coming to Mayo Clinic area / Arizona Republic
|
Brooks Rehabilitation announced plans for a $70 million clinic to treat patients with traumatic brain injuries, strokes, spinal cord injuries and other complex conditions near the Mayo Clinic at 64th Street and Mayo Boulevard, continuing a trend of biomedical companies opening their doors in the Valley.
Bioscience
Sampath Rangasamy’s personal journey leading to improved diabetes treatment
TGen researcher and Flinn seed grants awardee creates app to guide injection of insulin By Brian PowellFlinn Foundation Sampath Rangasamy was just a child when he was taken by his father past the rice fields and palm trees of his rural South India farming village to a nearby medical clinic. He had been losing weight, […]
Bioscience
Arizona Bioscience News: U of A president salary; Journey Venture Studio; Ivy Brian Center clinical trial; Tech Launch Arizona sets record
Regents approve new U of A president’s salary, contract / Arizona Daily Star
|
Suresh Garimella has formally been appointed to serve as the 23rd president of the University of Arizona, with an annual base salary of $810,000. He will begin his tenure on Oct. 1.
Bioscience
Arizona Bioscience News: COVID-19 and dementia; Fall Tech Talent Summit; C-Path awarded $250K
A groundbreaking study aims to determine if long COVID-19 could lead to another type of dementia / KJZZ |
Barrow Neurological Institute is launching a new study to determine the impacts of long COVID-19 on neurological function and if the disease could lead to another, new type of dementia.
For information about Bioscience, please contact:
bioscience@flinn.org or (602) 744-6831
